Modern Medicine News

Vitamin D deficiency associated with pediatric obesityVitamin D deficiency in children is associated with being overweight while sufficiency is associated with a healthy BMI, researchers reported in December.
Cancer adversely affects sexual functioning in young adultsMore than half of young adults between ages 18 and 39 with a cancer diagnosis reported problems with sexual function, according to a 2-year longitudinal study.
Detecting genital arousal much harder in women with arousal-specific sexual dysfunctionWomen with arousal-specific sexual dysfunction are significantly less likely to perceive when their genitals are sexually aroused compared to women who have decreased sexual function or are sexually functional, according to an analysis of data from 5 studies
Novel IOL may be key to preventing negative dysphotopsia
New products from CuteraCutera announces its North American launch of Juliet, an Er:YAG laser device for women’s vaginal health and aesthetics, and Secret RF, a fractional radiofrequency microneedling device.
The latest research on PRPStudy finds adding PRP to fat grafting improves recovery time, but not cosmetic outcomes or patient satisfaction.
Irregular corneas pose challenges for toric IOLs
How artificial intelligence may transform optometry
How artificial intelligence may transform optometryArtificial intelligence (AI) is evolving around us. Thomas A. Wong, OD, looks at how AI has impacted our world and how it is set to impact patient treatment in optometry.
Cornerstone therapy in atopic dermatitisMoisturizers were described as the “cornerstone of therapy” in atopic dermatitis in the 2014 AAD guidelines for topical therapies in atopic dermatitis, but the products differ greatly by ingredients which can improve the condition or make it worse.
Azathioprine and methotrexate safe and effective for atopic dermatitisSystem immunosuppressive treatment is often required to control patients with moderate to severe atopic eczema who have an inadequate response to intensive topical therapy, and, apart from cyclosporin A and dupilumab, such agents need to be prescribed off label and there is little data to guide clinicians.